37820 Federal Register / Vol. 83, No. 149 / Thursday, August 2, 2018 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Cancer 

Advisory Board. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. The open 

session will be videocast and can be 

accessed from the NIH Videocasting and 

Podcasting website (http://

videocast.nih.gov). 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Advisory Board. 

Date: August 14, 2018. 

Open: 1:00 p.m. to 2:45 p.m. 

Agenda: Director’s and Program reports 

and presentations; business of the Board. 

Closed: 2:55 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute—Shady 

Grove, 9609 Medical Center Drive, Room 

TE406, Rockville, MD 20850 (Virtual 

Meeting). 

Contact Person: Paulette S. Gray, Ph.D., 

Executive Secretary, Division of Extramural 

Activities, National Cancer Institute—Shady 

Grove, National Institutes of Health, 9609 

Medical Center Drive, Room 7W444, 

Bethesda, MD 20892, 240–276–6340, grayp@

mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to scheduling 

difficulties. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NCI-Shady Grove campus. Visitors 

will be asked to show one form of 

identification (for example, a governmentissued photo ID, driver’s license, or passport) 

and to state the purpose of their visit. 

Information is also available on the 

Institute’s/Center’s home page: http://

deainfo.nci.nih.gov/advisory/ncab/ncab.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: July 26, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16492 Filed 8–1–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Chemosensory Systems. 

Date: August 1, 2018. 

Time: 2:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: M. Catherine Bennett, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5182, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1766, bennettc3@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: July 27, 2018. 

Sylvia L. Neal, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16506 Filed 8–1–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Secretary; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Muscular Dystrophy 

Coordinating Committee (MDCC). 

The meeting will be open to the 

public and accessible by teleconference. 

Participation is limited to space 

available. Individuals who plan to 

participate and need special assistance, 

such as reasonable accommodations, 

should notify the Contact Person listed 

below in advance of the meeting. 

Name of Committee: Muscular Dystrophy 

Coordinating Committee. 

Type of meeting: Open Meeting. 

Date: September 17, 2018. 

Time: 2:00 p.m. to 5:00 p.m. *Eastern 

Time*—Approximate end time. 

Agenda: The purpose of this meeting is to 

bring together committee members, 

representing government agencies, patient 

advocacy groups, other voluntary health 

organizations, and patients and their families 

to update one another on progress relevant to 

the Action Plan for the Muscular Dystrophies 

and to coordinate activities and discuss gaps 

and opportunities leading to better 

understanding of the muscular dystrophies, 

advances in treatments, and improvements in 

patients’ and their families’ lives. Prior to the 

meeting, an agenda will be posted to the 

MDCC website: https://mdcc.nih.gov/. 

Registration: To register, please contact 

Emily Carifi: Emily.Carifi@nih.gov. 

WebEx/Phone Access: 

Join WebEx Meeting: https://

nih.webex.com/nih/j.php?MTID=

m1c5fd34513186c7c87ebeeee5af47f05; 

Meeting number (access code): 628 888 

923, Meeting password: fEN63PND 

Join by Phone: 1–650–479–3208 Call-in toll 

number (US/Canada) 

Global call-in numbers: https://

nih.webex.com/nih/globalcallin.php?

serviceType=MC&ED=701170342&toll

Free=0. 


daltland on DSKBBV9HB2PROD with NOTICES